The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Research Report 2025
Synopsis
Methylated RNA Immunoprecipitation Sequencing uses sepecific antibodies (m6A, m5C, etc.) to modify the targeted RNAs. After the modification, Immunoprecipitation is then induced to sepecifically enrich & collect those antibody-modified RNAs. Then, use high-throughput sequencing to detect the modified RNAs.
The global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The study of RNA modifications, such as N6-methyladenosine (m6A), has gained significant attention in the fields of molecular biology and genomics. This increased interest in epitranscriptomics has driven demand for techniques like MeRIP-Seq to investigate RNA modifications. MeRIP-Seq has primarily been used in academic and research settings to understand the functional roles of RNA modifications. Research institutions and universities have been key customers for MeRIP-Seq reagents and services. While still in the early stages, there is growing interest in applying MeRIP-Seq and RNA modification analysis to clinical research, including cancer biology and neurological disorders. This presents opportunities for companies to develop diagnostic tools and therapies based on RNA modifications.
This report aims to provide a comprehensive presentation of the global market for Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq).
Report Scope
The Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Epigentek
Illumina
Merck
Cloudseq Biotech Inc.
CD Genomics
Arraystar
LC Sciences
Segment by Type
Whole Transcriptome Sequencing
Incomplete Transcriptome Sequencing
Segment by Application
Cell Differentiation Study
Developmental Biology Study
Disease Development Study
Heat Shock Response Study
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Methylated RNA Immunoprecipitation Sequencing uses sepecific antibodies (m6A, m5C, etc.) to modify the targeted RNAs. After the modification, Immunoprecipitation is then induced to sepecifically enrich & collect those antibody-modified RNAs. Then, use high-throughput sequencing to detect the modified RNAs.
The global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The study of RNA modifications, such as N6-methyladenosine (m6A), has gained significant attention in the fields of molecular biology and genomics. This increased interest in epitranscriptomics has driven demand for techniques like MeRIP-Seq to investigate RNA modifications. MeRIP-Seq has primarily been used in academic and research settings to understand the functional roles of RNA modifications. Research institutions and universities have been key customers for MeRIP-Seq reagents and services. While still in the early stages, there is growing interest in applying MeRIP-Seq and RNA modification analysis to clinical research, including cancer biology and neurological disorders. This presents opportunities for companies to develop diagnostic tools and therapies based on RNA modifications.
This report aims to provide a comprehensive presentation of the global market for Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq).
Report Scope
The Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Epigentek
Illumina
Merck
Cloudseq Biotech Inc.
CD Genomics
Arraystar
LC Sciences
Segment by Type
Whole Transcriptome Sequencing
Incomplete Transcriptome Sequencing
Segment by Application
Cell Differentiation Study
Developmental Biology Study
Disease Development Study
Heat Shock Response Study
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Whole Transcriptome Sequencing
1.2.3 Incomplete Transcriptome Sequencing
1.3 Market by Application
1.3.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cell Differentiation Study
1.3.3 Developmental Biology Study
1.3.4 Disease Development Study
1.3.5 Heat Shock Response Study
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Perspective (2019-2030)
2.2 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Growth Trends by Region
2.2.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Region (2019-2024)
2.2.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Region (2025-2030)
2.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Dynamics
2.3.1 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Industry Trends
2.3.2 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Drivers
2.3.3 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Challenges
2.3.4 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Revenue
3.1.1 Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Revenue (2019-2024)
3.1.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Players (2019-2024)
3.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue
3.4 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Concentration Ratio
3.4.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue in 2023
3.5 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Key Players Head office and Area Served
3.6 Key Players Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product Solution and Service
3.7 Date of Enter into Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Breakdown Data by Type
4.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Type (2019-2024)
4.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Type (2025-2030)
5 Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Breakdown Data by Application
5.1 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Historic Market Size by Application (2019-2024)
5.2 Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
6.2 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024)
6.4 North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
7.2 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024)
7.4 Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
8.2 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2019-2024)
8.4 Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
9.2 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024)
9.4 Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (2019-2030)
10.2 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024)
10.4 Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Epigentek
11.1.1 Epigentek Company Detail
11.1.2 Epigentek Business Overview
11.1.3 Epigentek Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.1.4 Epigentek Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.1.5 Epigentek Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.2.4 Illumina Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.3.4 Merck Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Cloudseq Biotech Inc.
11.4.1 Cloudseq Biotech Inc. Company Detail
11.4.2 Cloudseq Biotech Inc. Business Overview
11.4.3 Cloudseq Biotech Inc. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.4.4 Cloudseq Biotech Inc. Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.4.5 Cloudseq Biotech Inc. Recent Development
11.5 CD Genomics
11.5.1 CD Genomics Company Detail
11.5.2 CD Genomics Business Overview
11.5.3 CD Genomics Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.5.4 CD Genomics Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.5.5 CD Genomics Recent Development
11.6 Arraystar
11.6.1 Arraystar Company Detail
11.6.2 Arraystar Business Overview
11.6.3 Arraystar Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.6.4 Arraystar Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.6.5 Arraystar Recent Development
11.7 LC Sciences
11.7.1 LC Sciences Company Detail
11.7.2 LC Sciences Business Overview
11.7.3 LC Sciences Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Introduction
11.7.4 LC Sciences Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
11.7.5 LC Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Whole Transcriptome Sequencing
Table 3. Key Players of Incomplete Transcriptome Sequencing
Table 4. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Region (2019-2024)
Table 8. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Region (2025-2030)
Table 10. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Trends
Table 11. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Drivers
Table 12. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Challenges
Table 13. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Restraints
Table 14. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Players (2019-2024)
Table 16. Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) as of 2023)
Table 17. Ranking of Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product Solution and Service
Table 21. Date of Enter into Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Type (2019-2024)
Table 25. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Type (2025-2030)
Table 27. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Application (2019-2024)
Table 29. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue Market Share by Application (2025-2030)
Table 31. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Epigentek Company Detail
Table 47. Epigentek Business Overview
Table 48. Epigentek Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
Table 49. Epigentek Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024) & (US$ Million)
Table 50. Epigentek Recent Development
Table 51. Illumina Company Detail
Table 52. Illumina Business Overview
Table 53. Illumina Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
Table 54. Illumina Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024) & (US$ Million)
Table 55. Illumina Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
Table 59. Merck Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Cloudseq Biotech Inc. Company Detail
Table 62. Cloudseq Biotech Inc. Business Overview
Table 63. Cloudseq Biotech Inc. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
Table 64. Cloudseq Biotech Inc. Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024) & (US$ Million)
Table 65. Cloudseq Biotech Inc. Recent Development
Table 66. CD Genomics Company Detail
Table 67. CD Genomics Business Overview
Table 68. CD Genomics Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
Table 69. CD Genomics Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024) & (US$ Million)
Table 70. CD Genomics Recent Development
Table 71. Arraystar Company Detail
Table 72. Arraystar Business Overview
Table 73. Arraystar Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
Table 74. Arraystar Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024) & (US$ Million)
Table 75. Arraystar Recent Development
Table 76. LC Sciences Company Detail
Table 77. LC Sciences Business Overview
Table 78. LC Sciences Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Product
Table 79. LC Sciences Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024) & (US$ Million)
Table 80. LC Sciences Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Type: 2023 VS 2030
Figure 3. Whole Transcriptome Sequencing Features
Figure 4. Incomplete Transcriptome Sequencing Features
Figure 5. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Application: 2023 VS 2030
Figure 7. Cell Differentiation Study Case Studies
Figure 8. Developmental Biology Study Case Studies
Figure 9. Disease Development Study Case Studies
Figure 10. Heat Shock Response Study Case Studies
Figure 11. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Report Years Considered
Figure 12. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Region: 2023 VS 2030
Figure 15. Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Players in 2023
Figure 16. Global Top Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Revenue in 2023
Figure 18. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Country (2019-2030)
Figure 20. United States Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Country (2019-2030)
Figure 24. Germany Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Region (2019-2030)
Figure 32. China Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Country (2019-2030)
Figure 40. Mexico Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Share by Country (2019-2030)
Figure 44. Turkey Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Epigentek Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
Figure 47. Illumina Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
Figure 48. Merck Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
Figure 49. Cloudseq Biotech Inc. Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
Figure 50. CD Genomics Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
Figure 51. Arraystar Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
Figure 52. LC Sciences Revenue Growth Rate in Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
